Diabetic Macular Edema
📧 Sign up to get email alerts when something new happens for Diabetic Macular Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-02Clinical Trial Update: Dextenza vs Prednisolone Acetate After Cataract Surgery for Patients With Diabetes [Phase 4]
The Phase 4 trial comparing Dextenza to prednisolone acetate after cataract surgery in diabetic patients has been withdrawn. No further resu…
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: An Observational Study to Investigate the Use of Aflibercept 8 mg to Treat Adult Patients With Neovascular Age-Related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME) in a Real-World Setting
A clinical trial investigating aflibercept 8 mg for neovascular age-related macular degeneration and diabetic macular edema in real-world se…
-
CLINICAL_TRIALS withdrawal · 2024-06-05Clinical Trial Update: Unilateral Bevacizumab for Bilateral Diabetic Macular Edema [Phase 4]
A Phase 4 trial evaluating unilateral bevacizumab for bilateral diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: Use of Intravitreal Bevacizumab in Patients With Diffuse Diabetic Macular Edema [Phase 3]
A Phase 3 trial evaluating intravitreal bevacizumab for diffuse diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-06-03Clinical Trial Update: POSTERIOR SUB-TENON'S Avastin [Phase 4]
A Phase 4 clinical trial of Avastin (bevacizumab) delivered via posterior sub-Tenon’s injection for diabetic macular edema has been withdraw…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2024-05-30Clinical Trial Update: Vitrectomy Without Internal Limiting Membrane Removal in the Treatment of Diffuse Diabetic Macular Edema: a Comparative Kenalog Vs Bevacizumab Intravitreal Injection Vs Control Study [Phase 3]
Phase 3 trial comparing intravitreal Kenalog, intravitreal Bevacizumab, and control for diffuse diabetic macular edema was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-10-02Clinical Trial Update: Combined Ranibizumab and Iluvien for Diabetic Macular Oedema [Phase 2, Phase 3]
A clinical trial evaluating combined ranibizumab and Iluvien for diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-08-02Clinical Trial Update: Non-Responsive Diabetic Macular Edema and Spironolactone [Phase 4]
A Phase 4 clinical trial investigating spironolactone for non-responsive diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-03-04Clinical Trial Update: Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 3]
Phase 3 trial comparing brolucizumab to aflibercept for diabetic macular edema was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2020-07-31Clinical Trial Update: Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema [Phase 2, Phase 3]
Clinical trial comparing laser therapy vs bevacizumab injection for diabetic macular edema was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-08-22Clinical Trial Update: Retinal Ganglion Cell Function After Intravitreous Ranibizumab in Patients With Diabetic Macular Edema [Phase 4]
A Phase 4 clinical trial assessing retinal ganglion cell function after intravitreal ranibizumab in diabetic macular edema has been withdraw…
-
CLINICAL_TRIALS withdrawal · 2018-06-14Clinical Trial Update: Intravitreal Alfibercept for Center Involved DME Previously Managed With Intravitreal Ranibizumab [Phase 4]
A phase 4 clinical trial evaluating intravitreal aflibercept for center-involved diabetic macular edema previously managed with ranibizumab …
-
CLINICAL_TRIALS withdrawal · 2017-08-22Clinical Trial Update: Fluocinolone Acetonide Insert (ILUVIEN®) for Diabetic Macular Edema (FAD) Study [Phase 4]
Phase 4 trial investigating the fluocinolone acetonide insert (ILUVIEN) for diabetic macular edema has been withdrawn. The sponsor listed is…
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: 24 Week Study to Compare Systemic VEGF-levels of Ranibizumab and Aflibercept in DME. [Phase 4]
A Phase 4 trial comparing systemic VEGF levels after ranibizumab versus aflibercept in diabetic macular edema was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-25Clinical Trial Update: Autofluorescence in Uveitic and Diabetic Macular Edema
A clinical trial assessing autofluorescence in uveitic and diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-10-27Clinical Trial Update: Systemic VEGF Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema [Phase 4]
Phase 4 trial evaluating systemic VEGF protein dynamics after intravitreal ranibizumab versus aflibercept in patients with diabetic macular …
-
CLINICAL_TRIALS withdrawal · 2016-09-15Clinical Trial Update: Safety Study of Intravitreal EBI-031 Given as a Single or Repeat Injection to Subjects With Diabetic Macular Edema [Phase 1]
A Phase 1 safety trial of intravitreal EBI-031 for diabetic macular edema was withdrawn, including single and repeat injection cohorts.
-
CLINICAL_TRIALS withdrawal · 2016-08-26Clinical Trial Update: Combined aPproach to Treatment Using Ranibizumab and Efalizumab for Diabetic Macular Edema Study: The CAPTURE DME Study [Phase 1]
Phase 1 CAPTURE DME trial investigating ranibizumab with efalizumab for diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-06-01Clinical Trial Update: Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME) [Phase 2]
Phase 2 trial evaluating Squalamine lactate eye drops with ranibizumab for diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-11Clinical Trial Update: A Study of the Safety and Tolerability of Intravitreal LKA651 in Patients With Diabetic Macular Edema [Phase 1]
Phase 1 study evaluating intravitreal LKA651 for diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-05-04Clinical Trial Update: A Phase 2 Study Exploring The Safety And Efficacy Of Novel Drug Treatment In Subjects With Diabetic Macular Edema (DME) [Phase 2]
Pfizer-sponsored Phase 2 clinical trial investigating a novel drug for diabetic macular edema has been withdrawn from the study.
-
CLINICAL_TRIALS withdrawal · 2014-07-30Clinical Trial Update: Frequent Dosing Regimen of Lucentis for Subjects With Persistent Diabetic Macular Edema Despite Standard antiVEGF Dosing [Phase 2]
A Phase 2 trial evaluating a more frequent Lucentis dosing regimen for persistent diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-03-17Clinical Trial Update: A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease [Phase 3]
A Phase 3 trial comparing islet cell transplantation with medical therapy for diabetic retinopathy and diabetic macular edema has been withd…
-
CLINICAL_TRIALS withdrawal · 2013-05-03Clinical Trial Update: Ranibizumab as a Rescue Therapy for Diabetic Macular Edema [Phase 2]
The Phase 2 trial of ranibizumab as rescue therapy for diabetic macular edema has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2012-12-07Clinical Trial Update: Safety Study of ALG- 1001 to Treat Diabetic Macular Edema [Phase 1, Phase 2]
The Phase 1/2 safety trial of ALG-1001 for diabetic macular edema was withdrawn.